Join our webinar on BioVendor solutions for tick-borne disease diagnostics, bringing together the clinical, technical and commercial perspectives needed to discuss the portfolio confidently with laboratory customers.
Our product managers will cover Lyme borreliosis, tick-borne encephalitis and anaplasmosis, from first-line antibody testing and confirmation to the assessment of more complex cases. We will look at how CLIA, EIA/SmartEIA, Microblot-Array (MBA) and BLOT-LINE fit into different laboratory workflows, testing volumes and diagnostic needs.
The clinical and technical part will include antigen profiles, neuroborreliosis, co-infections, cross-reactivity and specialist sample types, with a focus on what these considerations mean for method selection and result interpretation.
The commercial part will translate this knowledge into the sales conversation: how to qualify a laboratory, identify gaps in its current workflow, recognise opportunities for complementary methods, position the BioVendor portfolio against competing solutions and respond to common objections.
Date: September 16, 2026
Time: 10:00–12:00
Interested in joining the webinar?
Contact us at zuzana.gavacova@biovendor.com to register your interest.